AnatomyOrganismsDiseasesChemicals and DrugsAnalytical, Diagnostic and Therapeutic Techniques and EquipmentPsychiatry and PsychologyPhenomena and ProcessesDisciplines and OccupationsAnthropology, Education, Sociology and Social PhenomenaHumanitiesInformation ScienceNamed GroupsHealth CareGeographicals
AlaninePlacebo EffectDouble-Blind MethodAlanine TransaminaseAlanine RacemaseInterleukin-1betabeta 2-MicroglobulinTreatment OutcomeAlanine DehydrogenaseQuestionnairesTime FactorsReceptors, Adrenergic, betaCross-Over StudiesIntegrin beta3Risk FactorsProspective StudiesCross-Sectional StudiesFollow-Up StudiesMolecular Sequence DataTransforming Growth Factor betaAnalysis of VarianceAmino Acid SequenceCohort StudiesRandomized Controlled Trials as TopicMutagenesis, Site-DirectedDose-Response Relationship, DrugPilot ProjectsUnited StatesLongitudinal StudiesSeverity of Illness IndexRecombinant ProteinsIntegrin alpha5beta1Integrin beta4Aspartate AminotransferasesBinding SitesBase SequenceMutationIntegrin alpha6beta4Age FactorsKineticsIntegrin beta Chainsbeta 2-Glycoprotein IAdministration, OralAmino Acid SubstitutionCell LineSingle-Blind MethodAmino AcidsReceptors, Adrenergic, beta-2Drug Therapy, CombinationIntegrin alpha4beta1Neuropsychological TestsHealth Knowledge, Attitudes, PracticeIntegrin alpha2beta1Clinical Trials as TopicResearch DesignPatient ComplianceCells, CulturedSex FactorsQuality of LifePain MeasurementLogistic ModelsInterviews as TopicResearch SubjectsCognitionBody Mass IndexLiverModels, MolecularInterleukin-1IntegrinsCase-Control StudiesBlood PressureAntigens, CD29Psychomotor PerformanceChronic DiseaseBiological MarkersLinear ModelsRNA, MessengerMagnetic Resonance ImagingMotivationReproducibility of ResultsSmokingIntegrin alpha6beta1Focus GroupsHIV InfectionsPhosphorylationPsychiatric Status Rating ScalesPainIncidenceRisk AssessmentAffectDepressionDrug Administration ScheduleObesityExerciseBrainReceptors, Adrenergic, beta-1Reaction TimeSignal TransductionAdrenergic beta-AgonistsProtein Conformation